We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

163 hedge funds and large institutions have $451M invested in Acorda Therapeutics in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 80 increasing their positions, 39 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 39

51% more call options, than puts

Call options by funds: $1.82M | Put options by funds: $1.21M

11% less funds holding

Funds holding: 184 → 163 (-21)

41% less capital invested

Capital invested by funds: $761M → $451M (-$310M)

51% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 35

Holders
163
Holders Change
-21
Holders Change %
-11.41%
% of All Funds
3.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
80
Reduced
39
Closed
35
Calls
$1.82M
Puts
$1.21M
Net Calls
+$613K
Net Calls Change
+$3.26M

Top Buyers

1
BBA
Baker Bros. Advisors
New York
+$17.6M
2
PA
Perceptive Advisors
New York
+$11.5M
3
Renaissance Technologies
Renaissance Technologies
New York
+$5.6M
4
State Street
State Street
Massachusetts
+$5.35M
5
OAM
Oxford Asset Management
United Kingdom
+$3.06M

Top Sellers

1
SCM
Scopia Capital Management
New York
-$11.6M
2
ClearBridge Investments
ClearBridge Investments
New York
-$8.06M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$6.93M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$3.61M
5
OM
Opaleye Management
Massachusetts
-$3.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
76
VOYA Investment Management
Georgia
$474K +$168K +137 +36%
CS
77
Credit Suisse
Switzerland
$467K +$28.3K +23 +5%
PAM
78
Panagora Asset Management
Massachusetts
$460K -$215K -175 -26%
New York State Teachers Retirement System (NYSTRS)
79
New York State Teachers Retirement System (NYSTRS)
New York
$455K – – –
California Public Employees Retirement System
80
California Public Employees Retirement System
California
$453K +$22.1K +18 +4%
Ohio Public Employees Retirement System (OPERS)
81
Ohio Public Employees Retirement System (OPERS)
Ohio
$433K -$225K -183 -28%
Canada Life
82
Canada Life
Manitoba, Canada
$383K – – –
JG
83
Jefferies Group
New York
$381K +$130K +106 +34%
DCM
84
Dupont Capital Management
Delaware
$366K +$273K +222 +126%
Walleye Trading
85
Walleye Trading
New York
$334K +$444K +361 +18,050%
New York State Common Retirement Fund
86
New York State Common Retirement Fund
New York
$328K -$247K -201 -36%
SIM
87
Spark Investment Management
New York
$307K -$3.3M -2,684 -89%
ASN
88
Advisory Services Network
Georgia
$307K +$35.6K +29 +10%
JIR
89
James Investment Research
Ohio
$278K -$41.8K -34 -10%
DekaBank Deutsche Girozentrale
90
DekaBank Deutsche Girozentrale
Germany
$269K +$109K +89 +42%
State Board of Administration of Florida Retirement System
91
State Board of Administration of Florida Retirement System
Florida
$259K – – –
AIG
92
American International Group
New York
$254K +$3.69K +3 +1%
Comerica Bank
93
Comerica Bank
Texas
$253K -$25.8K -21 -6%
FDCDDQ
94
Federation des caisses Desjardins du Quebec
Quebec, Canada
$242K +$83.6K +68 +35%
Thrivent Financial for Lutherans
95
Thrivent Financial for Lutherans
Minnesota
$238K +$8.6K +7 +3%
MAM
96
Martingale Asset Management
Massachusetts
$232K – – –
UBS AM
97
UBS AM
Illinois
$232K +$16K +13 +5%
Manulife (Manufacturers Life Insurance)
98
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$228K +$2.46K +2 +0.8%
TPSF
99
Texas Permanent School Fund
Texas
$208K +$2.46K +2 +0.9%
State of Tennessee, Department of Treasury
100
State of Tennessee, Department of Treasury
Tennessee
$205K +$13.5K +11 +5%
2 3
4
5 6

ACOR Hedge Fund Activity: Q2 2019 in Review

163 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2019, worth a combined $451M — down 41% from $761M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of ACOR and 17 opened new positions — a net loss of 18 holders — while 39 trimmed existing stakes and 80 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $17.6M. The largest seller was Scopia Capital Management, cutting an estimated $11.6M.

  • 163 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2019, down from 184 in Q1 2019.
  • Funds reported $451M of Acorda Therapeutics stock for Q2 2019, down 41% quarter-over-quarter.
  • 17 funds opened new Acorda Therapeutics positions in Q2 2019 and 35 closed out, a net change of -18 holders.
  • The largest Acorda Therapeutics buyer in Q2 2019 was Baker Bros. Advisors, an estimated $17.6M added.
  • The largest Acorda Therapeutics seller in Q2 2019 was Scopia Capital Management, an estimated $11.6M sold.

Based on aggregated 13F filings for Q2 2019.